Item nonresponse on the Myeloproliferative Neoplasms Symptom Assessment Form (MPN-SAF): a comparison of missing data strategies

被引:4
作者
Mazza, Gina L. [1 ]
Kunze, Katie L. [1 ]
Langlais, Blake T. [1 ]
Kosiorek, Heidi E. [1 ]
DeWees, Todd A. [1 ]
Geyer, Holly L. [2 ]
Scherber, Robyn M. [3 ]
Mesa, Ruben A. [3 ]
Dueck, Amylou C. [1 ]
机构
[1] Mayo Clin, Hlth Sci Res, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA
[2] Mayo Clin, Internal Med, Phoenix, AZ USA
[3] Univ Texas Hlth San Antonio, Mays Canc Ctr, San Antonio, TX USA
关键词
Item nonresponse; missing data; proration; Myeloproliferative Neoplasms Symptom Assessment Form; quality of life; patient-reported outcome; QUALITY-OF-LIFE; THERAPY; MYELOFIBROSIS; RUXOLITINIB; FATIGUE; BURDEN;
D O I
10.1080/10428194.2018.1548705
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Administering questionnaires to patients is an efficient and effective method for assessing patients' symptoms. However, item nonresponse (skipped questions) potentially compromises the utility of these questionnaires. Using an international sample of 2,067 patients with myeloproliferative neoplasms, we evaluated the impact of item nonresponse on scoring of the Myeloproliferative Neoplasms Symptom Assessment Form Total Symptom Score (MPN-SAF TSS or MPN-10). We characterized item nonresponse on the MPN-10 and compared strategies for addressing item nonresponse (available-case analysis, proration, and multiple imputation) on the MPN-10 (multi-symptom assessment) and Brief Fatigue Inventory (BFI; single-symptom assessment). Characteristics of multi-symptom assessments would be expected to adversely affect proration, yet proration and multiple imputation provided very similar results for both the MPN-10 and BFI. This is likely because the MPN-10 item missing data rates were low, consistent with prior clinic- and internet-based studies. These results support the published scoring method for the MPN-10 (proration).
引用
收藏
页码:1789 / 1795
页数:7
相关论文
共 22 条
[1]   Myeloproliferative neoplasm patient symptom burden and quality of life: Evidence of significant impairment compared to controls [J].
Anderson, Lesley A. ;
James, Glen ;
Duncombe, Andrew S. ;
Mesa, Ruben ;
Scherber, Robyn ;
Dueck, Amylou C. ;
de Vocht, Frank ;
Clarke, Mike ;
McMullin, Mary F. .
AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (10) :864-870
[2]  
Bell Melanie L, 2016, BMC Res Notes, V9, P479
[3]  
Cohen J., 1988, STAT POWER ANAL BEHA, DOI 10.4324/9780203771587
[4]   The Patient-Reported Outcome (PRO) Consortium: Filling Measurement Gaps for PRO End Points to Support Labeling Claims [J].
Coons, S. J. ;
Kothari, S. ;
Monz, B. U. ;
Burke, L. B. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (05) :743-748
[5]   Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs [J].
Emanuel, Robyn M. ;
Dueck, Amylou C. ;
Geyer, Holly L. ;
Kiladjian, Jean-Jacques ;
Slot, Stefanie ;
Zweegman, Sonja ;
te Boekhorst, Peter A. W. ;
Commandeur, Suzan ;
Schouten, Harry C. ;
Sackmann, Federico ;
Kerguelen Fuentes, Ana ;
Hernandez-Maraver, Dolores ;
Pahl, Heike L. ;
Griesshammer, Martin ;
Stegelmann, Frank ;
Doehner, Konstanze ;
Lehmann, Thomas ;
Bonatz, Karin ;
Reiter, Andreas ;
Boyer, Francoise ;
Etienne, Gabriel ;
Ianotto, Jean-Christophe ;
Ranta, Dana ;
Roy, Lydia ;
Cahn, Jean-Yves ;
Harrison, Claire N. ;
Radia, Deepti ;
Muxi, Pablo ;
Maldonado, Norman ;
Besses, Carlos ;
Cervantes, Francisco ;
Johansson, Peter L. ;
Barbui, Tiziano ;
Barosi, Giovanni ;
Vannucchi, Alessandro M. ;
Passamonti, Francesco ;
Andreasson, Bjorn ;
Ferarri, Maria L. ;
Rambaldi, Alessandro ;
Samuelsson, Jan ;
Birgegard, Gunnar ;
Tefferi, Ayalew ;
Mesa, Ruben A. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (33) :4098-4103
[6]  
Enders C. K., 2010, APPL MISSING DATA AN
[7]   Functional assessment of cancer therapy (FACT-G): Non-response to individual questions [J].
Fairclough, DL ;
Cella, DF .
QUALITY OF LIFE RESEARCH, 1996, 5 (03) :321-329
[8]  
Fayers PM, 1998, STAT MED, V17, P679, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<679::AID-SIM814>3.3.CO
[9]  
2-O
[10]   Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development [J].
Geyer, Holly L. ;
Dueck, Amylou C. ;
Scherber, Robyn M. ;
Mesa, Ruben A. .
MEDIATORS OF INFLAMMATION, 2015, 2015